Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

RIZZO, Sergio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.485
EU - Europa 4.003
AS - Asia 3.313
SA - Sud America 561
Continente sconosciuto - Info sul continente non disponibili 485
AF - Africa 109
OC - Oceania 48
Totale 19.004
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.298
SG - Singapore 1.182
RU - Federazione Russa 921
IT - Italia 916
CN - Cina 897
FI - Finlandia 534
BR - Brasile 413
DE - Germania 392
HK - Hong Kong 290
VN - Vietnam 279
UA - Ucraina 217
GB - Regno Unito 208
PL - Polonia 175
FR - Francia 157
IE - Irlanda 150
KR - Corea 121
JP - Giappone 106
BD - Bangladesh 104
CA - Canada 99
SE - Svezia 79
IN - India 78
NL - Olanda 58
AR - Argentina 47
AU - Australia 47
TR - Turchia 43
RO - Romania 38
IQ - Iraq 37
BE - Belgio 35
ES - Italia 34
MX - Messico 31
CI - Costa d'Avorio 30
AT - Austria 29
EC - Ecuador 27
CO - Colombia 24
ZA - Sudafrica 20
IR - Iran 19
VE - Venezuela 19
ID - Indonesia 18
MA - Marocco 18
UZ - Uzbekistan 18
CR - Costa Rica 15
MY - Malesia 14
PH - Filippine 12
KE - Kenya 10
PT - Portogallo 10
PK - Pakistan 9
CH - Svizzera 8
CL - Cile 8
DK - Danimarca 8
LB - Libano 8
SA - Arabia Saudita 8
AE - Emirati Arabi Uniti 7
JM - Giamaica 7
NP - Nepal 7
OM - Oman 7
PY - Paraguay 7
AZ - Azerbaigian 6
NI - Nicaragua 6
PE - Perù 6
UY - Uruguay 6
EE - Estonia 5
EU - Europa 5
IL - Israele 5
JO - Giordania 5
PA - Panama 5
TN - Tunisia 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
UG - Uganda 5
AL - Albania 4
BG - Bulgaria 4
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
GT - Guatemala 4
HN - Honduras 4
KZ - Kazakistan 4
TH - Thailandia 4
BH - Bahrain 3
BO - Bolivia 3
EG - Egitto 3
GE - Georgia 3
NO - Norvegia 3
PS - Palestinian Territory 3
SN - Senegal 3
BB - Barbados 2
ET - Etiopia 2
HU - Ungheria 2
LT - Lituania 2
MK - Macedonia 2
NG - Nigeria 2
QA - Qatar 2
RS - Serbia 2
AM - Armenia 1
AO - Angola 1
BF - Burkina Faso 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CU - Cuba 1
Totale 18.502
Salva come PNG Salva come JPEG
Città #
Fairfield 1.351
Ashburn 1.208
Singapore 742
Woodbridge 623
San Jose 619
Seattle 526
Chandler 523
Houston 492
Wilmington 470
Cambridge 407
Ann Arbor 391
Hong Kong 284
Palermo 226
Council Bluffs 194
Moscow 178
Helsinki 148
Zgierz 145
Dublin 144
Beijing 143
Los Angeles 134
Medford 124
Des Moines 122
New York 115
Dallas 108
Jacksonville 107
Santa Clara 106
Boardman 98
Nanjing 96
Altamura 94
Tokyo 93
Ho Chi Minh City 88
San Diego 84
Chicago 82
Princeton 79
The Dalles 79
Lauterbourg 75
Lawrence 71
Dearborn 66
Hanoi 59
Frankfurt am Main 56
Phoenix 54
Hefei 52
São Paulo 50
Buffalo 47
Seoul 43
London 41
Ludwigshafen am Rhein 41
Rome 39
Milan 38
Jinan 36
Brussels 33
Tulsa 32
Seongnam 31
Shenyang 31
Tianjin 31
Abidjan 30
Orem 29
Hebei 28
Nanchang 28
Panama City 27
Bremen 26
Warsaw 25
Changsha 24
Denver 23
Amsterdam 22
Guangzhou 22
Brooklyn 21
Kumar 21
Atlanta 20
Toronto 20
Columbus 19
Da Nang 19
Montreal 19
Nuremberg 19
Kitzingen 18
Springfield 18
Munich 17
Izmir 16
Ningbo 16
Saint Petersburg 16
Berlin 15
Boydton 15
Jiaxing 15
Orange 15
Shanghai 15
San Paolo di Civitate 14
Tehran 14
Baghdad 13
Manchester 13
San Francisco 13
Sydney 13
Enschede 12
San José 12
Ankara 11
Belo Horizonte 11
Bogotá 11
Fuzhou 11
Pune 11
Surrey 11
Vienna 11
Totale 12.148
Salva come PNG Salva come JPEG
Nome #
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial 366
EGFR inhibition in NSCLC: New findings…. and opened questions? 358
Male breast cancer. 355
PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis 355
Analysis of miRNA expression profile induced by short term starvation in breast cancer cells treated with doxorubicin 344
"Back to a false normality": New intriguing mechanisms of resistance to PARP inhibitors 327
Anti-endothelin drugs in solid tumors 311
EGF Induces STAT3-Dependent VEGF Expression in HT-29 colon cancer cells 311
I tumori della mammella e/o dell’ovaio di tipo eredofamiliare: strategie di prevenzione nelle donne ad alto rischio 310
A headlight on liquid biopsies: a challenging tool for breast cancer management 309
Breast cancer genome-wide association studies: there is strength in numbers 308
Co-expression of CD133+/CD44+in human colon cancer and liver metastasis 307
Analysis of germline gene copy number variants of patients with sporadic pancreatic adenocarcinoma reveals specific variations 306
Antiemetic prophylaxis containing Palonosetron (P) alone or in combination with Aprepitant (A) in the treatment of advanced soft tissue sarcoma (STS) patients with epirubicin and ifosfamide 298
Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer? 298
Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects 296
The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients 295
Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients 294
Early Skin Toxicity as a Predictive Factor for Tumor Control in Hepatocellular Carcinoma Patients Treated with Sorafenib. 292
BRCA1 and BRCA2 germline mutations in sicilian breast and/or ovarian cancer families and their association with familial profiles 290
KIR2DL3 and the KIR ligand groups HLA-A-Bw4 and HLA-C2 predict the outcome of hepatitis B virus infection. 288
Metastatic site location influences the diagnostic accuracy of ctDNA EGFR- mutation testing in NSCLC patients: a pooled analysis 283
BRCA1 and BRCA2 variants of uncertain clinical significance and their implications for genetic counseling 282
Triple negative breast cancer: Shedding light onto the role of pi3k/akt/mtor pathway 282
How to Deal with Second Line Dilemma in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis 278
Monoclonal antibodies in gastrointestinal cancers 273
Nintedanib in NSCLC: Evidence to date and place in therapy 264
Human equilibrative nucleoside transporter 1 (hENT1) levels predict response to gemcitabine in patients with biliary tract cancer (BTC) 261
Monoclonal antibodies and antibody fragments: state of the art and future perspectives in the treatment of non-haematological tumors 260
What can platinum offer yet in the treatment of PS2 NSCLC patients? A systematic review and meta-analysis 258
EGFR genomic alterations in cancer: prognostic and predictive values 254
Analysis of systemic inflammatory biomarkers in neuroendocrine carcinomas of the lung: prognostic and predictive significance of NLR, LDH, ALI, and LIPI score 252
Downregulated expression of Cdc25A gene in MCF-7 breast cancer cell 249
Biomarkers and efficacy: Are we nearly there yet? 249
MicroRNAs in colorectal cancer stem cells: new regulators of cancer stemness? 248
Beyond evidence-based data: Scientific rationale and tumor behavior to drive sequential and personalized therapeutic strategies for the treatment of metastatic renal cell carcinoma 248
Bevacizumab in association with de Gramont 5-fluorouracil/folinic acid in patients with oxaliplatin-, irinotecan-, and cetuximab-refractory colorectal cancer: a single-center phase 2 trial. 244
Non-Small Cell Lung Cancer Harboring Concurrent EGFR Genomic Alterations: A Systematic Review and Critical Appraisal of the Double Dilemma 244
Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapy 244
Sex steroids, carcinogenesis, and cancer progression 233
PML expression in soft tissue sarcoma: Prognostic and predictive value in alkylating agents/antracycline-based first line therapy. 232
Hereditary ovarian cancer 231
New molecular targets in bone metastases 231
The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second- or third-line for advanced non-small-cell lung cancer patients with wild-type or unknown EGFR status 231
HER2-positive male breast cancer: An update 231
A literature-based meta-analysis of the comparison between Gemcitabine-based combination and monochemotherapy for the treatment of advanced non-small cell lung cancer in elderly patients 228
The Risk of Toxicities from Trastuzumab, Alone or in Combination, in an Elderly Breast Cancer Population 227
Prognostic role of human equilibrative transporter 1 (hENT1) in patients with resected gastric cancer 226
Gene signatures in CRC and liver metastasis 221
The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis 217
Driver mutations and differential sensitivity to targeted therapies: a new approach to the treatment of lung adenocarcinoma 216
Bortezomib: a new pro-apoptotic agent in cancer treatment. 214
Predicting efficacy and toxicity in the era of targeted therapy: focus on anti-EGFR and anti-VEGF molecules 212
Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy? 210
Is BRCA1-5083del19, identified in breast cancer patients of Sicilian origin, a Calabrian founder mutation? 210
Looking for the best immune-checkpoint inhibitor in pre-treated NSCLC patients: An indirect comparison between nivolumab, pembrolizumab and atezolizumab 210
Monoclonal antibodies for the treatment of non-haematological tumours: Update of an expanding scenario 209
PML as a potential predictive factor of oxaliplatin/fluoropyrimidine-based first line chemotherapy efficacy in colorectal cancer patients 202
The molecular changes driving the carcinogenesis in Barrett's esophagus: Which came first, the chicken or the egg? 197
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting 196
Clinical parameters to guide decision-making in elderly metastatic colorectal CANCER patients treated with intensive cytotoxic and anti-angiogenic therapy 195
An update on the conquests and perspectives of cardio-oncology in the field of tumor angiogenesistargeting TKI-based therapy 195
Gists eredo familiari e pediatrici: aspetti biomolecolari e clinici. 191
The role of microRNAs in driving EGFR-TKI resistance in NSCLC cell lines 187
Circulating tumor DNA (ctDNA) as predictive biomarker in NSCLC patients treated with Nivolumab 179
Low dose splenic irradiation in myelofibrosis: outcomes and toxicity of three radiation schedule 177
The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet? 176
Promyelocytic leukemia (PML) gene expression is a prognostic factor in ampullary cancer patients 174
Early stage nasal vestibule tumors: safety and efficacy of HDR brachyterapy in elderly patients 168
The long and winding road to useful predictive factors for anti-egfr therapy in metastatic colorectal carcinoma: The KRAS/BRAF pathway 164
Could starvation minimize chemotherapy-induced toxicities? 163
Prognostic and predictive biomarkers for targeted therapy in NSCLC: For whom the bell tolls? 161
La consulenza genetica in oncologia: implicazioni biomolecolari e cliniche. 158
Uncoupling Protein 2 as genetic risk factor for systemic lupus erythematosus: association with malondialdehyde levels and intima media thickness 156
"ONCOGENE ADDICTED SOLID TUMORS: BIOMARKERS PROGNOSTIC AND PREDICTIVE OF RESISTANCE OR SENSITIVITY TO MOLECULAR TARGETED THERAPIES IN CRC 155
The effects of enzalutamide and abiraterone on skeletal related events and bone radiological progression free survival in castration resistant prostate cancer patients: An indirect comparison of randomized controlled trials 151
Moving the target on the optimal adjuvant strategy for resected pancreatic cancers: A systematic review with meta-analysis 145
The prognostic role of KRAS and BRAF in patients undergoing surgical resection of colorectal cancer liver metastasis: a systematic review and meta-analysis 116
Cardiovascular risk in patients without known cardiovascular disease 109
null 9
Totale 19.004
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.436
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.436
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022799 0 0 0 38 63 46 87 52 105 140 96 172
2022/20231.502 147 300 30 189 150 230 111 102 142 8 55 38
2023/2024616 30 81 50 37 36 110 73 78 2 15 12 92
2024/20251.593 30 108 97 126 55 67 162 151 86 166 197 348
2025/20265.793 464 171 306 439 566 792 830 669 485 531 275 265
2026/20271.410 393 221 765 31 0 0 0 0 0 0 0 0
Totale 19.004